LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06558799 · TERMINATED
Trial details
- NCT number
- NCT06558799
- Sponsor
- NovoCure GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-14
- Primary completion
- 2026-02-23
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.